首页> 外国专利> NOVEL PHOSPHORYLATION ACCELERATOR OF EIF2α REGULATING ENDOPLASMIC RETICULUM STRESS RESPONSE AND INTEGRATED STRESS RESPONSE

NOVEL PHOSPHORYLATION ACCELERATOR OF EIF2α REGULATING ENDOPLASMIC RETICULUM STRESS RESPONSE AND INTEGRATED STRESS RESPONSE

机译:EIF2α的新型磷酸化促进剂调节内质网应激反应和综合应激反应

摘要

PROBLEM TO BE SOLVED: To provide a novel eIF2α phosphorylation accelerator.SOLUTION: According to the present invention, there is provided a compound represented by the formula (4) or a bupranolol derivative (1-phenoxy-3-alkylamino-propane-2-ol derivative). Here, phosphorylation of eIF2α is promoted through a path different from that of PERK and GCN2. There is also provided a therapeutic agent for the prevention or treatment of metabolism, cranial nerve, cancer, immune disorders. [X and Y each independently represent H, a halogen atom, a C1-4 alkyloxy group, etc., or X and Y together form a 1,2-di-oxyethylene group, etc.; Z represents H, a halogen atom, a C1-4 alkyloxy group, etc.]SELECTED DRAWING: None
机译:解决的问题:提供新颖的eIF2α磷酸化促进剂。解决方案:根据本发明,提供由式(4)表示的化合物或丁丙诺醇衍生物(1-苯氧基-3-烷基氨基丙烷-2-醇衍生物)。在此,通过不同于PERK和GCN2的途径促进了eIF2α的磷酸化。还提供了用于预防或治疗代谢,颅神经,癌症,免疫疾病的治疗剂。 [X和Y分别独立地表示H,卤素原子,碳原子数1〜4的烷氧基等,或者X和Y一起形成1,2-二氧乙烯基等。 Z代表H,卤原子,C1-4烷氧基等。]

著录项

  • 公开/公告号JP2017193527A

    专利类型

  • 公开/公告日2017-10-26

    原文格式PDF

  • 申请/专利权人 OYADOMARI SEIICHI;

    申请/专利号JP20160095654

  • 发明设计人 OYADOMARI SEIICHI;

    申请日2016-04-18

  • 分类号A61K31/137;A61K31/138;A61P3;A61P25;A61P35;A61P37/02;A61P43;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 14:01:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号